6-53009535-G-A

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_014920.5(CILK1):​c.1525C>T​(p.Pro509Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000304 in 1,611,524 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P509A) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0018 ( 2 hom., cov: 32)
Exomes 𝑓: 0.00015 ( 1 hom. )

Consequence

CILK1
NM_014920.5 missense

Scores

1
18

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 2.51

Publications

2 publications found
Variant links:
Genes affected
CILK1 (HGNC:21219): (ciliogenesis associated kinase 1) Eukaryotic protein kinases are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. This gene encodes an intestinal serine/threonine kinase harboring a dual phosphorylation site found in mitogen-activating protein (MAP) kinases. The protein localizes to the intestinal crypt region and is thought to be important in intestinal epithelial cell proliferation and differentiation. Alternative splicing has been observed at this locus and two variants, encoding the same isoform, have been identified. [provided by RefSeq, Jul 2008]
CILK1 Gene-Disease associations (from GenCC):
  • endocrine-cerebro-osteodysplasia syndrome
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp
  • juvenile myoclonic epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.004268497).
BP6
Variant 6-53009535-G-A is Benign according to our data. Variant chr6-53009535-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 1680537.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAd4 at 2 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CILK1NM_014920.5 linkc.1525C>T p.Pro509Ser missense_variant Exon 12 of 14 ENST00000676107.1 NP_055735.1 Q9UPZ9-1A0A024RD59

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CILK1ENST00000676107.1 linkc.1525C>T p.Pro509Ser missense_variant Exon 12 of 14 NM_014920.5 ENSP00000501692.1 Q9UPZ9-1
CILK1ENST00000350082.10 linkc.1546C>T p.Pro516Ser missense_variant Exon 12 of 14 1 ENSP00000263043.8 A0A7I2PIU1
CILK1ENST00000356971.3 linkc.1525C>T p.Pro509Ser missense_variant Exon 13 of 15 2 ENSP00000349458.3 Q9UPZ9-1

Frequencies

GnomAD3 genomes
AF:
0.00172
AC:
262
AN:
152212
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00574
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00124
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00191
GnomAD2 exomes
AF:
0.000394
AC:
99
AN:
251376
AF XY:
0.000287
show subpopulations
Gnomad AFR exome
AF:
0.00560
Gnomad AMR exome
AF:
0.000145
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000880
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.000150
AC:
219
AN:
1459194
Hom.:
1
Cov.:
29
AF XY:
0.000121
AC XY:
88
AN XY:
726094
show subpopulations
African (AFR)
AF:
0.00551
AC:
184
AN:
33412
American (AMR)
AF:
0.000179
AC:
8
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26124
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39684
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86198
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53414
Middle Eastern (MID)
AF:
0.000520
AC:
3
AN:
5766
European-Non Finnish (NFE)
AF:
9.01e-7
AC:
1
AN:
1109556
Other (OTH)
AF:
0.000365
AC:
22
AN:
60318
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
13
26
38
51
64
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00178
AC:
271
AN:
152330
Hom.:
2
Cov.:
32
AF XY:
0.00180
AC XY:
134
AN XY:
74490
show subpopulations
African (AFR)
AF:
0.00594
AC:
247
AN:
41580
American (AMR)
AF:
0.00124
AC:
19
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5192
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68028
Other (OTH)
AF:
0.00189
AC:
4
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
14
28
43
57
71
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000680
Hom.:
1
Bravo
AF:
0.00200
ESP6500AA
AF:
0.00477
AC:
21
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000420
AC:
51
Asia WGS
AF:
0.00144
AC:
5
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Jul 20, 2021
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Jul 03, 2025
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: CILK1 c.1525C>T (p.Pro509Ser) results in a non-conservative amino acid change in the encoded protein sequence. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change. The variant allele was found at a frequency of 0.0003 in 1611524 control chromosomes, predominantly at a frequency of 0.0057 within the African or African-American subpopulation in the gnomAD database (v4), including 3 homozygotes. The observed variant frequency within African or African-American control individuals in the gnomAD database exceeds the estimated maximal expected allele frequency for a pathogenic variant in CILK1 causing CILK1-Related Disorders phenotype. To our knowledge, no occurrence of c.1525C>T in individuals affected with CILK1-Related Disorders and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 1680537). Based on the evidence outlined above, the variant was classified as likely benign. -

not provided Benign:1
Nov 25, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

CILK1-related disorder Benign:1
Nov 01, 2021
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.065
BayesDel_addAF
Benign
-0.43
T
BayesDel_noAF
Benign
-0.38
CADD
Benign
14
DANN
Benign
0.78
DEOGEN2
Benign
0.011
T;T
Eigen
Benign
-0.32
Eigen_PC
Benign
-0.053
FATHMM_MKL
Uncertain
0.79
D
LIST_S2
Benign
0.37
.;T
M_CAP
Benign
0.0050
T
MetaRNN
Benign
0.0043
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.53
N;N
PhyloP100
2.5
PrimateAI
Benign
0.32
T
PROVEAN
Benign
1.0
N;N
REVEL
Benign
0.11
Sift
Benign
0.95
T;T
Sift4G
Benign
0.94
T;T
Polyphen
0.0
B;B
Vest4
0.065
MVP
0.68
MPC
0.25
ClinPred
0.024
T
GERP RS
5.6
Varity_R
0.018
gMVP
0.19
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs141663565; hg19: chr6-52874333; API